President & CEO of Audentes Therapeutics (NASDAQ:BOLD), Patterson Matthew R, sells 2,850 shares worth $57,007

According to Audentes Therapeutics's most recent Form 4 filing with the SEC dated Jul 14 08:01 PM, company President & CEO, Patterson Matthew R disclosed selling 2,850 shares at a cost of $20.00. At the time of this transaction (Jul 12), this trade was worth $57,007 in total. As of Jul 12, Patterson Matthew R now owns 198,964 shares in total worth about $4,074,782.72.

For the last few recent trades made by Audentes Therapeutics (NASDAQ:BOLD) President & CEO, Patterson Matthew R, we have the following information:

  1. SEC Form 4 filing: Jul 13: Sold 12,150 shares at the rate of $20.00 per share. Total worth of this trade was $243,052. Total number of shares owned as of Jul 13 were 186,814
Posted by on Saturday July 15 2017, 9:54 AM EST. All trademarks acknowledged. Filed under Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Log in